X4 Pharmaceuticals, Inc

XFORNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$35.1M

▲ 1273.2% YoY

Net Income

-$79.2M

▼ 111.5% YoY

EPS

$-1.87

▲ 66.5% YoY

Cash

$217.0M

▲ 289.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.